-
1
-
-
77956049370
-
CORRONA Investigators. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis
-
Sokolove J., Strand V., Greenberg J.D., Curtis J.R., Kavanaugh A., Kremer J.M., et al. CORRONA Investigators. Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis. Ann Rheum Dis 2010, 69(9):1612-1617.
-
(2010)
Ann Rheum Dis
, vol.69
, Issue.9
, pp. 1612-1617
-
-
Sokolove, J.1
Strand, V.2
Greenberg, J.D.3
Curtis, J.R.4
Kavanaugh, A.5
Kremer, J.M.6
-
2
-
-
77955292814
-
Austrian Society of Gastroenterology and Hepatology. A decade of infliximab: the Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease
-
Miehsler W., Novacek G., Wenzl H., Vogelsang H., Knoflach P., Kaser A., et al. Austrian Society of Gastroenterology and Hepatology. A decade of infliximab: the Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease. J Crohns Colitis 2010, 4(3):221-256.
-
(2010)
J Crohns Colitis
, vol.4
, Issue.3
, pp. 221-256
-
-
Miehsler, W.1
Novacek, G.2
Wenzl, H.3
Vogelsang, H.4
Knoflach, P.5
Kaser, A.6
-
3
-
-
33847686821
-
Serious liver disease induced by infliximab
-
Tobon G.J., Cañas C., Jaller J.J., Restrepo J.C., Anaya J.M. Serious liver disease induced by infliximab. Clin Rheumatol 2007, 26(4):578-581.
-
(2007)
Clin Rheumatol
, vol.26
, Issue.4
, pp. 578-581
-
-
Tobon, G.J.1
Cañas, C.2
Jaller, J.J.3
Restrepo, J.C.4
Anaya, J.M.5
-
4
-
-
78650807484
-
Subacute liver failure induced by adalimumab
-
Hagel S., Bruns T., Theis B., Herrmann A., Stallmach A. Subacute liver failure induced by adalimumab. Int J Clin Pharmacol Ther 2011, 49(1):38-40.
-
(2011)
Int J Clin Pharmacol Ther
, vol.49
, Issue.1
, pp. 38-40
-
-
Hagel, S.1
Bruns, T.2
Theis, B.3
Herrmann, A.4
Stallmach, A.5
-
5
-
-
4344614501
-
Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis
-
Esteve M., Saro C., González-Huix F., Suarez F., Forn M., Vivier J.M. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut 2004, 53(9):1363-1365.
-
(2004)
Gut
, vol.53
, Issue.9
, pp. 1363-1365
-
-
Esteve, M.1
Saro, C.2
González-Huix, F.3
Suarez, F.4
Forn, M.5
Vivier, J.M.6
-
6
-
-
0037532694
-
Hepatits B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate
-
Ostuni P., Botsios C., Punzi L., Sfriso P., Todesco S. Hepatits B reactivation in a chronic hepatitis B surface antigen carrier with rheumatoid arthritis treated with infliximab and low dose methotrexate. Ann Rheum Dis 2003, 62(7):686-687.
-
(2003)
Ann Rheum Dis
, vol.62
, Issue.7
, pp. 686-687
-
-
Ostuni, P.1
Botsios, C.2
Punzi, L.3
Sfriso, P.4
Todesco, S.5
-
7
-
-
0038504830
-
Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still's disease
-
Michel M., Duvoux C., Hezode C., Cherqui D. Fulminant hepatitis after infliximab in a patient with hepatitis B virus treated for an adult onset Still's disease. J Rheumatol 2003, 30(7):1624-1625.
-
(2003)
J Rheumatol
, vol.30
, Issue.7
, pp. 1624-1625
-
-
Michel, M.1
Duvoux, C.2
Hezode, C.3
Cherqui, D.4
-
8
-
-
78650431965
-
Autoimmine hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab
-
Cravo M., Silva R., Serrano M. Autoimmine hepatitis induced by infliximab in a patient with Crohn's disease with no relapse after switching to adalimumab. BioDrugs 2010, 24(Suppl. 1):25-27.
-
(2010)
BioDrugs
, vol.24
, Issue.SUPPL. 1
, pp. 25-27
-
-
Cravo, M.1
Silva, R.2
Serrano, M.3
-
9
-
-
77953542643
-
Infliximab-related hepatitis: discussion of a case and review of the literature
-
Mancini S., Amorotti E., Vecchio S., Ponz de Leon M., Roncucci L. Infliximab-related hepatitis: discussion of a case and review of the literature. Intern Emerg Med 2010, 5(3):193-200.
-
(2010)
Intern Emerg Med
, vol.5
, Issue.3
, pp. 193-200
-
-
Mancini, S.1
Amorotti, E.2
Vecchio, S.3
Ponz de Leon, M.4
Roncucci, L.5
-
10
-
-
77957017374
-
Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab
-
Haennig A., Bonnet D., Thebault S., Alric L. Infliximab-induced acute hepatitis during Crohn's disease therapy: absence of cross-toxicity with adalimumab. Gastroenterol Clin Biol 2010, 34(8-9):e7-e8.
-
(2010)
Gastroenterol Clin Biol
, vol.34
, Issue.8-9
-
-
Haennig, A.1
Bonnet, D.2
Thebault, S.3
Alric, L.4
-
11
-
-
67849084977
-
Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept
-
Carlsen K.M., Riis L., Madsen O.R. Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept. Clin Rheumatol 2009, 28(8):1001-1003.
-
(2009)
Clin Rheumatol
, vol.28
, Issue.8
, pp. 1001-1003
-
-
Carlsen, K.M.1
Riis, L.2
Madsen, O.R.3
-
12
-
-
0022457904
-
Hepatotoxicity after treatment with sulfasalazine
-
197-198.
-
Haines J.D. Hepatotoxicity after treatment with sulfasalazine. Postgrad Med 1986, 79(6):193-194. 197-198.
-
(1986)
Postgrad Med
, vol.79
, Issue.6
, pp. 193-194
-
-
Haines, J.D.1
-
13
-
-
0033145613
-
Fulminant hepatitis in two children treated with sulfasalazine for Crohn disease
-
Besnard M., Debray D., Durand P., Fabre M., Chardot C., Cézard J.P. Fulminant hepatitis in two children treated with sulfasalazine for Crohn disease. Arch Pediatr 1999, 6(6):643-646.
-
(1999)
Arch Pediatr
, vol.6
, Issue.6
, pp. 643-646
-
-
Besnard, M.1
Debray, D.2
Durand, P.3
Fabre, M.4
Chardot, C.5
Cézard, J.P.6
-
14
-
-
0036786888
-
Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines
-
Ransford R.A., Langman M.J. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut 2002, 51(4):536-539.
-
(2002)
Gut
, vol.51
, Issue.4
, pp. 536-539
-
-
Ransford, R.A.1
Langman, M.J.2
-
15
-
-
0026460940
-
Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine
-
Hautekeete M.L., Bourgeois N., Potvin P., Duville L., Reynaert H., Devis G., et al. Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine. Gastroenterology 1992, 103(6):1925-1927.
-
(1992)
Gastroenterology
, vol.103
, Issue.6
, pp. 1925-1927
-
-
Hautekeete, M.L.1
Bourgeois, N.2
Potvin, P.3
Duville, L.4
Reynaert, H.5
Devis, G.6
|